Future global health emergency responses must be equitable and address people’s needs

MSF reacts to 2023 UN High-Level Meeting on Pandemic Prevention, Preparedness and Response (PPPR) declaration

MSF statement at the 5th Intergovernmental Negotiating Body (INB) on WHO Pandemic Accord

MSF statement at the Fourth meeting of the Intergovernmental Negotiating Body (INB) for a World Health Organization instrument on pandemic prevention, preparedness and response.

MSF Statement on EB152/13 - Strengthening clinical trials

MSF Statement on EB152/7 - Substandard and falsified medical products

MSF Statement on EB152/5 - Strengthening diagnostics capacity

MSF publicly announced its first Clinical Trial Transparency Policy (CTTP). The CTTP outlines MSF’s commitment to the open sharing of information and costs on clinical trials.

Multiple avenues must be taken to rapidly scale up global access to vaccines, treatments and tests, to save as many lives as possible

MSF spoke at a WTO-WHO high-level event on expanding global COVID-19 vaccine manufacturing to support equitable access

Dr Maria Guevara called on governments to immediately address the system failures that MSF, and healthcare workers all over the world, are witnessing.

Regarding the text of the declaration for the upcoming UN High-Level Meeting (HLM) on HIV/AIDS, MSF released this statement urging all countries to recognise and retain the full rights and use of international public health safeguards ...

MSF Statement on Agenda Item 74/13.5 - Antimicrobial Resistance (AMR) | Report by the Director-General

MSF Statement on Agenda Item 13.4 concerning the draft resolution, “Strengthening local production of medicines and other health technologies to improve access.”

MSF Statement on Agenda Item 13.2 - Non-Communicable Diseases and Oral Health

In their statement at a recent virtual event titled "COVID-19 and Vaccine Equity: What Can the WTO Contribute?" held on 14 April 2021, the EU Commission continued to defend a position that leaves a handful of pharmaceutical companies ...

We appeal to all WTO members to work together for a global solution that empowers all countries to protect all populations, and truly treat vaccines as a global public good. It is about saving lives at the end, not protecting systems.